ALTERATION OF CEREBROSPINAL-FLUID (CSF) PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE (ARA-C) BY TETRAHYDROURIDINE (THU)

被引：0
|
作者：
RICCARDI, R
CHABNER, B
GLAUBIGER, D
MASTRANGELO, R
POPLACK, D
机构：
[1] NCI,BETHESDA,MD 20205
[2] CATHOLIC UNIV,I-00168 ROME,ITALY
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1980年 / 21卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：160 / 160
页数：1
相关论文
共 50 条
  • [1] CEREBROSPINAL-FLUID (CSF) PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE (ARA-C)
    LOPEZ, JA
    KRIKORIAN, JG
    BEARDSLEY, GP
    AGARWAL, RP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 210 - 210
  • [2] EFFECT OF TETRAHYDROURIDINE (THU) ON METABOLISM OF CYTOSINE-ARABINOSIDE (ARA-C) IN HUMAN LEUKEMIC-CELLS
    CHOU, TC
    ARLIN, Z
    CLARKSON, B
    PHILIPS, FS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1976, 17 (MAR): : 142 - 142
  • [3] DOES THE METABOLITE URACIL ARABINOSIDE INHIBIT CYTOSINE-ARABINOSIDE (ARA-C) PENETRATION INTO THE CEREBROSPINAL-FLUID DURING HIGH-DOSE ARA-C THERAPY
    VANPROOIJEN, HC
    MUUS, P
    ROELOFS, JMM
    PUNT, K
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 36 (01): : 123 - 126
  • [4] THE CYTOSINE-ARABINOSIDE (ARA-C) SYNDROME
    CASTLEBERRY, RP
    CRIST, WM
    HOLBROOK, T
    MALLUH, A
    GADDY, D
    MEDICAL AND PEDIATRIC ONCOLOGY, 1981, 9 (03): : 257 - 264
  • [5] PLASMA AND CEREBROSPINAL-FLUID PHARMACOKINETICS OF CYTOSINE-ARABINOSIDE IN DOGS
    SCOTTMONCRIEFF, JCR
    CHAN, TCK
    SAMUELS, ML
    COOK, JR
    COPPOC, GL
    DENICOLA, DB
    RICHARDSON, RC
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 29 (01) : 13 - 18
  • [6] PHARMACOKINETICS OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    HANDE, KR
    STEIN, RS
    MCDONOUGH, DA
    WOLFF, SN
    CLINICAL RESEARCH, 1981, 29 (02): : A436 - A436
  • [7] CYTOSINE-ARABINOSIDE CEREBROSPINAL-FLUID KINETICS
    ZIMM, S
    COLLINS, JM
    MISER, J
    CHATTERJI, D
    POPLACK, DG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) : 826 - 830
  • [8] PHARMACOKINETICS OF ARA-C AND ARA-U IN PLASMA AND CSF AFTER HIGH-DOSE ADMINISTRATION OF CYTOSINE-ARABINOSIDE
    DEANGELIS, LM
    KREIS, W
    CHAN, K
    DANTIS, E
    AKERMAN, S
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (03) : 173 - 177
  • [9] PHASE-I STUDY OF TETRAHYDROURIDINE (THU) WITH ARABINOSYL CYTOSINE (ARA-C)
    WONG, P
    CURRIE, V
    MACKEY, R
    YOUNG, C
    BURCHENAL, J
    KRAKOFF, I
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 196 - 196
  • [10] TREATMENT OF AML WITH CYTOSINE-ARABINOSIDE (ARA-C) AND ANTHRACYCLINE
    PREISLER, H
    RUSTUM, Y
    HENDERSON, E
    BJORNSSON, S
    HIGBY, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 389 - 389
12345